
Drug development companies should prioritise strategic pharma collaborations to keep up with the next wave of immuno-oncology treatments, the chief …

Merck and Pfizer are partnering to run two Phase III trials of avelumab, an immuno-oncology treatment the companies hope to …

Sanofi and UCB have announced a new partnership that will see the companies research and develop new medicines together. Specifically, …

A leading Japanese pharma group says that the sector should see investment in fighting diseases of the developing world as …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

